Syngene International Receives Tax Penalty Relief Order for Assessment Year 2018-19

2 min read     Updated on 14 Mar 2026, 07:05 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Syngene International Limited has received a favorable tax order from the National Faceless Assessment Centre dated March 13, 2026, dropping penalty proceedings for Assessment Year 2018-19. The development follows the company's successful appeal that resulted in complete relief of Rs.2,78,45,669 in previously disallowed expenses. The penalty proceedings, initially initiated in March 2023, have now been formally concluded with no financial impact on the company.

35040931

*this image is generated using AI for illustrative purposes only.

Syngene International Limited has received a positive development in its tax litigation matters, with the National Faceless Assessment Centre dropping penalty proceedings for Assessment Year 2018-19. The company disclosed this update to stock exchanges on March 14, 2026, in compliance with SEBI Listing Regulations.

Tax Assessment Timeline and Developments

The tax matter originated with an order dated March 27, 2023, when the National Faceless Assessment Centre made a disallowance of expenses worth Rs.2,78,45,669 under sections 147 and 144B of the Income Tax Act for Assessment Year 2018-19. Simultaneously, the authority issued a show cause notice proposing to levy penalty in relation to this disallowance under sections 274 and 270A of the Act.

Key Timeline: Details
Initial Order: March 27, 2023 - Expense disallowance of Rs.2,78,45,669
Show Cause Notice: March 27, 2023 - Penalty proceedings initiated
Appeal Order: February 14, 2025 - Relief directed by appellate authority
Effect Order: September 11, 2025 - Full relief of Rs.2,78,45,669 granted
Penalty Dropped: March 13, 2026 - Penalty proceedings concluded

Successful Appeal Process

Syngene International challenged the initial assessment order before the National Faceless Appeal Centre. The appellate authority passed a favorable order on February 14, 2025, directing the Assessing Officer to verify details and allow relief to the company. Following this directive, the Assessing Officer issued an order on September 11, 2025, giving effect to the appellate order and granting complete relief of Rs.2,78,45,669.

Current Status and Financial Impact

Pursuant to the relief granted, the National Faceless Assessment Centre has now passed an order under section 270A of the Income Tax Act dated March 13, 2026, formally dropping the penalty proceedings that were initiated through the March 27, 2023 notice.

Current Position: Status
Expense Disallowance: Fully reversed - Rs.2,78,45,669 relief granted
Penalty Proceedings: Dropped completely
Financial Impact: No material impact expected
Compliance Status: No aberrations identified in latest order

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI Listing Regulations, providing comprehensive details of the tax matter resolution. Syngene International stated that no action is required from the company's side since the penalty proceedings have been dropped. The company believes there will be no material impact on its financials, operations, or activities from this development.

This resolution represents a complete closure of the tax litigation matter for Assessment Year 2018-19, with Syngene International successfully defending its position through the appellate process.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+4.15%+4.25%-5.71%-36.63%-37.80%-23.57%
like17
dislike

Syngene International Schedules Analyst Meeting with Alquity Investment Management on March 18, 2026

1 min read     Updated on 13 Mar 2026, 08:27 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Syngene International Limited has scheduled a virtual analyst/investor meeting with Alquity Investment Management on March 18, 2026, at 4:00 PM IST from Bengaluru. The company has confirmed that no Unpublished Price Sensitive Information will be disclosed during the one-to-one meeting, ensuring compliance with SEBI Regulation 30 requirements.

34959442

*this image is generated using AI for illustrative purposes only.

Syngene International Limited has announced a scheduled analyst/investor meeting with Alquity Investment Management, set to take place on March 18, 2026. The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The biotechnology services company has provided comprehensive details about the upcoming investor engagement:

Parameter: Details
Date: March 18, 2026
Participant: Alquity Investment Management
Meeting Type: Virtual
Format: One to One Meeting
Timing: 4:00 PM IST
Venue: Bengaluru

Regulatory Compliance

Syngene International has emphasized its commitment to regulatory compliance by explicitly stating that no Unpublished Price Sensitive Information (UPSI) will be disclosed during the analyst/investor meeting. This declaration ensures adherence to SEBI guidelines regarding information sharing with institutional investors and analysts.

The company has also confirmed that details of this meeting will be made available on its official website at www.syngeneintl.com , maintaining transparency with all stakeholders.

Corporate Communication

The formal intimation was signed by Chethan Yogesh, Company Secretary & Compliance Officer, and was digitally executed on March 13, 2026. The communication was addressed to both BSE Limited and National Stock Exchange of India Limited, ensuring proper disclosure to both major stock exchanges where the company's shares are listed.

This scheduled meeting represents part of Syngene International's ongoing investor relations activities, providing institutional investors with opportunities for direct engagement while maintaining strict compliance with regulatory requirements.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+4.15%+4.25%-5.71%-36.63%-37.80%-23.57%
like16
dislike

More News on Syngene International

1 Year Returns:-37.80%